Drug Guidance for Subsidy 02/01/2024 Insulin aspart (Fiasp) for treating diabetes mellitus NRThe Ministry of Health’s Drug Advisory Committee has not recommended insulin aspart (Fiasp) ... See all × 02/01/2024 Insulin aspart (Fiasp) for treating diabetes mellitus NRThe Ministry of Health’s Drug Advisory Committee has not recommended insulin aspart (Fiasp) for inclusion on the MOH List of Subsidised Drugs for treating diabetes mellitus due to limited clinical need and unfavourable cost effectiveness compared with alternative treatments.
INTRAVENOUS / SUBCUTANEOUS Select a brand starting with the letter: F FIASP SOLUTION FOR INJECTION IN VIAL 100U/ML [SIN15995P]